This study suggests that CPEF may exert its anti-obesity effects by promoting thermogenesis and fatty acid oxidation via inducing UCP1 and PPARα expression, and that hesperidin and neoponcirin may be responsible for these effects. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.